methionine sulfoximine has been researched along with Granulocytic Leukemia, Chronic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chigurupati, R; Frischer, H; Kennedy, EJ; Sivarajan, M | 1 |
Ballard, K; Jollow, DJ; Oatis, JE; Peters, RH; Stuart, RK | 1 |
2 other study(ies) available for methionine sulfoximine and Granulocytic Leukemia, Chronic
Article | Year |
---|---|
Glutathione, cell proliferation, and 1,3-bis-(2-chloroethyl)-1-nitrosourea in K562 leukemia.
Topics: Buthionine Sulfoximine; Carmustine; Cell Cycle; Cell Division; Cell Line; DNA Repair; DNA, Neoplasm; Dose-Response Relationship, Drug; Glutathione; Glutathione Reductase; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine Sulfoximine; Tumor Cells, Cultured | 1993 |
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells.
Topics: Antimetabolites; Buthionine Sulfoximine; Cell Line; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Interactions; Glutathione; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Methionine Sulfoximine; Sulfhydryl Compounds; Tumor Cells, Cultured | 1990 |